PDF
(Download)
|
- Peppermint (Mentha x piperita)
- Infantile Colic
| Date:
09-28-2012 | HC# 091261-457
|
Re: Effectiveness of Peppermint in the Treatment of Infantile Colic
Alves
JGB, Moraes de Brito RdCC, Cavalcanti TS. Effectiveness of Mentha piperita [sic] in
the treatment of infantile colic: a crossover study. Evid Based Complement Alternat Med. July 12, 2012;2012:981352. Doi:
10.1155/2012/981352.
Many
newborns suffer from infantile colic, characterized primarily by crying more
than 3 hours per day, 3 days a week for at least 3 weeks while hunger or other
illness are not factors. There are many theorized causes of this ailment with
none more prevalent than gastrointestinal problems, possibly arising from
hyperperistalsis, aerophagia, or cow's milk allergy. Peppermint (Mentha x piperita) leaves are commonly used for digestive problems and have
been found to provide relaxing effects on gastrointestinal muscle.1,2
This double-blind, crossover study on infantile colic compared the effects of
peppermint to simethicone (a mixture of polydimethylsiloxanes), a commonly used
pharmaceutical for the alleviation of gas based on reduction of the surface
tension of air bubbles.
The
study took place at the Instituto de Medicina Integral Professor Fernando Figueira
in Recife, Brazil. Infants between the ages of 15-60 days that were breastfed
only and had colic were included. Colic was diagnosed by "irritability,
restlessness, or crying" for 3 hours per day, 3 days per week for 3 weeks.
Enrolled infants were examined throughout the study to rule out other health
factors that may cause crying. Infants with illiterate mothers, residing
outside of Recife, born premature or with low birth weight (<2,500 g), not
thriving, or who had gastrointestinal disorders, an infection, a metabolic
disease, or allergies were excluded. Infants on any kind of therapy were also
excluded.
Enrolled
infants were randomized to either a treatment group consuming 1 liquid drop/kg
body weight of a "formulation" of peppermint leaves or liquid drops
equivalent to 2.5 mg/kg of simethicone for 7 days. No other information
regarding the peppermint liquid drop preparation was provided. After 3 days of
washout, infants received the opposite treatment for another 7 days. Infants
visited the clinic on the 7th and 17th days of the study.
It is stated that the peppermint and simethicone treatments were identical in
"weight, smell, color, taste, and package," and parents filled out a
standardized form to document frequency of crying, adherence to treatments, and
any adverse side effects. A stopwatch was given to parents to help quantify the
length of crying time. The sample size used for this study was determined by a preliminary
pilot study.
Of
a total of 313 infants, 30 infants had colic and were enrolled in the study,
and all infants completed the study. The average age of infants was 33 ± 11.1
days, with an average weight of 4.650 ± 415 g and height of 54.2 ± 3.0 cm. All
mothers received prenatal care and 16 (53.3%) had undergone cesarean section.
Maternal age ranged from 14 to 32 years (22.7 ± 5.4), and they had 10.4 years (±
2.5) of schooling. The occurrences of colic at baseline were 3.9 ± 1.1 times
per day with an average crying time of 192 ± 51.6 minutes. This was reduced to
1.6 ± 0.6 times per day for a duration of 111 ± 28 minutes at the end of the
study. There were no significant differences reported between the changes of
either treatment. Also, any significant differences as compared to baseline are
not reported. No adverse side effects were observed.
Although
parents observed decreases in crying occurrence and duration, this was not
significant between the peppermint and simethicone groups. It is mentioned that
peppermint oil has been used in children previously to treat other
gastrointestinal problems and has been shown to alleviate smooth muscle spasms
in vivo. The shortcomings of the study addressed include the issue that colic
gets better over time and that this study would not have been able to control
for improvement of colic in this manner. There was no control or placebo group
used to address this issue. It is also stated that treatment compliance was
monitored via parental reporting, and no independent oversight was used to
ensure protocol adherence. Other problems with this study include incomplete
reporting of data and lack of details concerning the peppermint preparation and
source; however, this study does report possible efficacy of peppermint for
treating infant colic in the absence of adverse side effects and provides a
foundation on which to base future clinical trials.
—Amy
C. Keller, PhD
References
1Blumenthal M, Goldberg
A, Brinckmann J, eds. Herbal Medicine:
Expanded Commission E Monographs. Austin,
TX: American Botanical Council; Newton, MA: Integrative Medicine Communications;
2000.
2Taylor BA, Luscombe
DK, Duthie HL. Inhibitory effect of peppermint oil on gastrointestinal smooth
muscle. Gut. October 1983;24(10):A992.
|